Filter Results
:
(512)
Show Results For
-
All HBS Web
(512)
- People (2)
- News (133)
- Research (127)
- Events (2)
- Multimedia (5)
- Faculty Publications (71)
Show Results For
-
All HBS Web
(512)
- People (2)
- News (133)
- Research (127)
- Events (2)
- Multimedia (5)
- Faculty Publications (71)
- 01 Sep 2014
- News
All For One
don’t know what the answer is. They have to act, not plan their way forward. Hill began to despair of finding an answer to her problem until a chance meeting with Pixar executive Greg Brandeau in the lobby of a biotech firm—Hill was there...
View Details
- 01 Jun 2007
- News
Mission Possible
“Rudy contends that if we can identify the other ten or twelve genes that are players, we can give the biotech industry so many more shots to come up with a therapy,” explains McCance, who, along with his cofounders, is privately...
View Details
- 25 Feb 2014
- First Look
First Look: February 25
recent firm performance? Purchase this case: http://hbr.org/product/say-on-pay-qualcomm-inc-shareholders-vote-maybe-in-2012/an/114005-PDF-ENG Harvard Business School Case 213-047 Aqua Bounty Valuation of a pre-revenue biotech company at...
View Details
Keywords:
Sean Silverthorne
- 01 Mar 2018
- What Do You Think?
Two Decades Later, is the 'New Economy' Finally Here?
second of these books, Exponential Organizations (“ExOs”), explores the impact of new technologies on organizations. These are organizations driven by such things as AI, robotics, biotech and bioinformatics, data science, and 3D printing....
View Details
Keywords:
by James Heskett
- 08 Jul 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Co-Founders, Anne-Marie Schoonbeek and Heleen van Poecke
internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her...
View Details
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
COVID taught us, the more we prepare now, the quicker we can get back to normal when the next pandemic hits. As I look back at Vaxess years, it has been fantastic to see life sciences grow at HBS and within the Boston biotech community. I...
View Details
- 07 Feb 2017
- First Look
First Look at New Research: February 7
case:https://cb.hbsp.harvard.edu/cbmp/product/517027-PDF-ENG Harvard Business School Case 617-022 Alnylam Pharmaceuticals: Building Value from the IP Estate (B) The leader of a pioneering biotech company in the siRNA space weighs his...
View Details
Keywords:
Sean Silverthorne
- 03 May 2011
- First Look
First Look: May 3
Business Model Gary P. Pisano, Ryan Johnson, and Carin-Isabel KnoopHarvard Business School Case 611-046 In the biotech world, the 18-year-old Munich-based company MorphoSys was a rarity: it was profitable. The company achieved this...
View Details
Keywords:
Sean Silverthorne
- 01 Dec 2010
- News
This Is What I Do
thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety View Details
- 01 May 2007
- First Look
First Look: May 1, 2007
drug development process; threats from biotech and generics competitors; pharmaceutical manufacturing, selling, and marketing; and pharmaceutical consumption in Europe, the third world, and the U.S. Merck and Pfizer are analyzed in-depth...
View Details
Keywords:
Sean Silverthorne
- 01 Sep 2012
- News
High Honors
companies, primarily in the computer and health-care realm. In the four decades since, Johnson has helped build the biotech industry and earned a reputation as a thoughtful investor, trusted adviser, and generous philanthropist. Among his...
View Details
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Download the paper: http://www.hbs.edu/research/pdf/09-099.pdf Cases & Course MaterialsAvid Radiopharmaceuticals: The Venture Debt Question Harvard Business School Case 809-086 The CEO of a promising biotech company must decide how...
View Details
Keywords:
Martha Lagace
- 12 May 2009
- First Look
First Look: May 12, 2009
this situation, donations are likely to decline, investment surplus has declined and biotech partners are challenged to finance joint projects as well as their own operations. Beall is striving to find a cure for cystic fibrosis while...
View Details
Keywords:
Martha Lagace
- 01 Sep 2009
- News
E Ink’s Wild Ride
that required a massive amount of investment before it could take off,” says Yoffie, who served on E Ink’s board from 1999 to 2004. “The truism is that getting to that point takes longer and costs more money than the most pessimistic forecast. It’s a very similar...
View Details
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
case:https://hbsp.harvard.edu/product/318082-PDF-ENG Harvard Business School Case 318-083 Sandra Brown Goes Digital (B): The Commitment Decision Sandra Brown, a middle manager at a biotech company who has led internal and external...
View Details
Keywords:
Dina Gerdeman
- 01 Dec 2004
- News
The Future of Stem Cells
year for research on existing lines, even as other countries are investing many times that amount. Says Cynthia Fisher (MBA ’90), president and CEO of BioMed 20/20 Technologies, a biotech and medical information products firm, “The...
View Details
Keywords:
Garry Emmons
- 12 Sep 2006
- First Look
First Look: September 12, 2006
organization's relational capacity. The benefits will reverberate throughout every dimension of the company's work. Financial Contracting in Biotech Strategic Alliances Authors:David T. Robinson and Toby E. Stuart Periodical:Journal of...
View Details
Keywords:
Sean Silverthorne
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
technological innovation, which is how the biotechs and some of the medical devices can get through these hurdles. But for a health service innovation, the payment hurdles are so massive it's masochistic. Then if you go into competition...
View Details
- Web
Podcast - Managing the Future of Work
technician. We have contracts with the United States government. We’re working on the vaccine response and tracking. We also provide lab technicians that are working with major pharmaceutical and biotech companies on breakthrough drugs....
View Details
- 01 Sep 2008
- News
Mara Aspinall
ASPINALL Illustration by Jack Unruh When you ask people about their great fears in life, virtually everyone talks about cancer,” says Mara G. Aspinall (MBA ’87), past president of Genzyme Genetics, a Westborough, Massachusetts-based division of the View Details